contact[at]op2lysis.com

The company
The Technology
Products
Indications
News
Contact

Search for:

A large number of successes in 2021!

Home
Corporate
A large number of successes in 2021!

Op2Lysis
January 2022
Corporate

You will find below a retrospective of 2021.

Articles récents

Funding for the ThromboSTROKE collaborative research project
Sucessful DRF toxicology Study
Retrospective – 2023 in a nutshell
Nominated for the GALIEN USA 2023 award “Best Startup”
Op2Lysis is a silver sponsor of the WICH 2023 conference and will have the opportunity to give two oral presentations to an expert audience in cerebral haemorrhage

Archives

October 2024
September 2024
January 2024
October 2023
September 2023
July 2023
January 2023
December 2022
September 2022
April 2022
January 2022

Catégories

Corporate
Event
Press Release
Technology

Biotechnology company that researches and develops innovative medicines

Supported by

SItemap

Contact
home
Indications
Legal Notice
News
Products
The company
The Technology

Recent Posts

Nominated for the GALIEN USA 2023 award “Best Startup”

October 12, 2023

Funding for the ThromboSTROKE collaborative research project

October 15, 2024

Sucessful DRF toxicology Study

September 03, 2024

Contact

FRANCE: 117 avenue Victor Hugo, 92100 Boulogne-Billancourt, France BELGIUM: Légia Park, Boulevard Patience et Beaujonc, 3, 4000 Liège, Belgium

Op2Lysis © 2022 All Rights Reserved – Legal notice – web agency : Bridge Communication